Rajeev Saggar
Patrimonio netto: 11 M $ in data 31/05/2026
Patrimonio netto: 11 M $ in data 31/05/2026
Rajeev Saggar is currently Chief Medical Officer at Liquidia Corp.
since 2022.
Former positions include Vice President-Clinical Development at Theravance Biopharma Us LLC from 2021 to 2022, and Medical Director-Pulmonary Hypertension & Fibrosis at The Banner-University Medical Center.
Education includes a doctorate from the University of California, Irvine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,19% | 13/04/2026 | 173.270 ( 0,19% ) | 11 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LIQUIDIA CORPORATION | Direttore Tecnico/Scientifico/R&S | 18/07/2022 |
| Società | Posizione | Fine |
|---|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Direttore Tecnico/Scientifico/R&S | 01/07/2022 |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale